What Treatment for Opioids Actually Looks Like

The first visit is mostly talking, and most of that talking is you.

I want your medical history — the whole thing, not just the opioid part. Heart, lungs, liver, kidneys, sleep, injuries, surgeries, pregnancies, infections, the medications you take and the ones you stopped. I want to know about pain, because for a great many people this started with pain that was real and is often still there. And I want to know about anxiety, depression, trauma, ADHD, and anything else that has been running in the background, because those things are frequently part of why opioids got a foothold and they do not go away on their own.

Then we get into what you are actually taking. Not the version that sounds most acceptable — the real one. How much, how often, how you take it, what time of day the first dose happens, how long it has been like this. Whether you have ever overdosed, or been given naloxone, or woken up somewhere with people around you.

And I want to know exactly what the substance is, which in 2026 is a harder question than it used to be. There is a real difference between someone taking prescribed oxycodone, someone using pressed pills bought on the street, someone using fentanyl, and someone using a concentrated 7-OH product from a smoke shop. They all produce opioid use disorder. They do not all behave the same way when we start medication, and getting this wrong is the single most common reason a first attempt goes badly. If you do not know what is in what you are taking, say so — that is useful information too, and it is extremely common.

I will usually check labs, and I will use urine drug testing. I want to be plain about that last one: in my office a drug test is a clinical instrument, not a character exam. It tells me what is actually in your system, which matters enormously when I am about to start a medication that interacts with it. Fentanyl and the chemicals made to imitate it do not show up on many standard panels, and things mixed into the supply — like xylazine, an animal sedative — show up on none of them unless we test for them on purpose. I read these results the way I read any other lab result: as information that shapes the plan. Nobody gets discharged from my practice for an unexpected result.

And then a question people are often surprised to be asked: what do you want?

Some people want to be on medication long term and be done thinking about this. Some want to stabilize and eventually taper off. Some want to stop everything today and are not interested in maintenance. Some are not sure and only know that the current situation is not survivable. All of those are legitimate places to start a conversation. I will tell you honestly what the medicine supports for your particular situation — and where I think a plan carries more risk than you may realize — and then we build something you actually agree with.

A plan you did not sign up for is not a plan.

Opioid withdrawal, unlike alcohol withdrawal, is not usually dangerous in itself — with real exceptions worth naming: severe vomiting and diarrhea can cause dehydration and electrolyte loss, vomiting while sedated carries a risk of aspiration, withdrawal in pregnancy can threaten the pregnancy, and people have died in jails from withdrawal that nobody managed. It is, however, one of the most miserable experiences a person can have, and misery is not a small clinical problem — it is the reason most solo attempts end where they end. Sweating, chills, gooseflesh, muscle and bone aches, cramping, nausea and diarrhea, restless legs, sleep that will not come, and an anxiety that feels like it is being pumped into you from outside. Nobody white-knuckles their way through that reliably, and needing help with it is not weakness.

The other thing worth saying out loud: the most dangerous moment in opioid use disorder is often not the drug itself but the return to it after a break. Tolerance falls fast. A dose that was ordinary three weeks ago can be fatal today. That is the single most important fact in this entire article, and I will come back to it.

Buprenorphine and the timing problem

Buprenorphine — you may know it as Suboxone, Subutex, or Zubsolv — is the medication I use most. It is a partial opioid, and that is the whole reason it works so well. Opioids act on docking points in your brain and body called receptors. Buprenorphine locks onto those docking points tightly, but only switches them on part way. Fentanyl and oxycodone switch them all the way on and keep going; buprenorphine reaches a limit and stops. That limit is why it is dramatically safer than what most of my patients arrive on.

That same tight grip creates the one real hurdle in starting it. If you take buprenorphine while a full opioid is still docked in your receptors, buprenorphine shoves it off and takes its place — and because buprenorphine only switches the receptor on part way, the effect drops like a stone. That crash is precipitated withdrawal: withdrawal set off by the medicine itself, arriving in minutes instead of coming on over hours. It is uncommon — though the data are thinner in the fentanyl era than in the years the older studies were done — it is rarely dangerous, and it is thoroughly unpleasant. One bad experience with it is enough to convince someone that buprenorphine "doesn't work for them" for years afterward. So I take the timing seriously.

Fentanyl has made this harder than it was a decade ago. It gets stored in body fat and hangs around far longer than it feels like it lasts, so the old rule of thumb about how long to wait is not always reliable. There are two general ways through it.

Which one we use depends on what you are taking, what has happened to you before, and what your life can actually accommodate. I will explain both and we will pick together.

Whichever route we take, I do not hand people a rigid countdown and wish them luck. You get a framework — what to take, when, what the ceiling is, what to do if symptoms escalate, and how to reach me while it is happening. Then we stay in close contact through it. Withdrawal is not one-size-fits-all, and a schedule written before symptoms start is a guess. I would rather respond to what is actually happening to you.

Alongside the buprenorphine, we treat the symptoms directly rather than asking you to tough them out. Clonidine or lofexidine for the sweating, the racing heart, and the crawling-out-of-your-skin feeling. Something for nausea. Something for diarrhea. Something for cramping and restless legs. Something for sleep, which in my experience is the symptom most likely to break someone's resolve at three in the morning on day two.

And sometimes outpatient is not the right setting. If you have unstable medical problems, if you are pregnant, if you are using multiple substances in a way that makes home management unsafe, or if home is simply not a place where this can happen, I will tell you plainly and help arrange a higher level of care. That is not me passing you off. It is me getting you through the hard part safely so we can do the real work afterward.

There are three medications for opioid use disorder, and I want to give you the honest shape of each.

Buprenorphine is where I start with most people. Once you are stabilized on an adequate dose, the withdrawal stops, the cravings quiet substantially, and — this is the part people do not expect — most of your day stops being about this. It is taken as a daily film or tablet, usually combined with naloxone in a formulation designed to discourage misuse. There is also extended-release injectable buprenorphine — Sublocade or Brixadi — given monthly (or weekly, for one Brixadi formulation). For people who do not want a daily reminder sitting on the counter, who travel, whose living situation makes storing medication a problem, or who know that the moment they decide to use is the same moment they would decide to skip a dose, the injection is often the better fit.

Methadone is a full opioid and remains, for a substantial number of people, the most effective option available — particularly for those with very high tolerance, long histories, and previous unsuccessful attempts on buprenorphine. I cannot dispense it from my office; federal law requires it be given through a licensed opioid treatment program. What I can do is tell you honestly when I think it is the right medicine for you, help you get connected, and stay involved in your care.

Methadone is not a lesser choice or a last resort, and anyone who tells you otherwise is repeating a prejudice rather than reporting the evidence.

Naltrexone is the third option and works in the opposite direction — it is a blocker. It sits in the opioid receptors and switches on nothing, so opioids cannot act. It is available as a daily pill or as the monthly Vivitrol injection. It is not an opioid, and your body does not become dependent on it, and for people who are firmly set against taking an opioid-based medication it is a real and legitimate choice.

Its limitation is real and I will not soft-pedal it: you have to be fully off opioids before starting it, or it will precipitate withdrawal. In practice that means roughly seven to ten days after short-acting opioids, and up to two weeks if you are coming off methadone or buprenorphine. That window is exactly when people are most vulnerable, and in the large randomized comparison of extended-release naltrexone against buprenorphine-naloxone, that hurdle was decisive — significantly fewer people assigned to naltrexone ever managed to start it, and that alone made the naltrexone group's overall outcomes worse. Among the people who did get successfully started on their assigned medication, the two performed similarly. That is a useful and honest summary: naltrexone works when you can get on it, and getting on it is the hard part.

How long?

Neither ASAM nor any serious body sets a time limit on treatment with buprenorphine or methadone, and I do not either. This is a chronic condition, and stopping effective medication is the moment risk goes back up — so when someone wants to taper off, we do it deliberately, slowly, with the rest of your supports in place, and with a clear plan for what happens if things wobble. Not in month one, and never as a condition of my continued involvement.

I am including this section because a growing share of the people arriving in my office with opioid use disorder did not get there through a prescription or through fentanyl. They got there through a product sold openly at a gas station.

Kratom leaf contains dozens of active chemicals. The main one is mitragynine, and on its own it is fairly mild — it acts on the same docking points as other opioids, but only lightly. The one that matters far more is 7-hydroxymitragynine, or 7-OH. There is only a trace of it in the raw leaf, and your body also makes a small amount of it out of mitragynine. It is a different animal entirely.

In the leaf, 7-OH makes up something on the order of a hundredth of a percent by weight. In the concentrated products now sold as tablets, shots, and gummies, it is the entire point. And 7-OH is no longer the end of it: chemists have made even stronger versions of it in a lab, including mitragynine pseudoindoxyl, MGM-15, and MGM-16.

The regulatory picture is moving, and it moved again while I was writing this. In July 2026 the DEA moved to place 7-OH above a specified threshold — roughly one part in two thousand by weight for plant material, or 1 mg in a single pill or serving of a finished product — into Schedule I, along with three synthetic relatives. As of this writing those three synthetics (mitragynine pseudoindoxyl, MGM-15, and MGM-16) are in Schedule I under a final temporary order; the 7-OH action itself is not yet final. Botanical kratom below the threshold is not covered. FDA has issued warning letters to companies marketing these products and has been explicit that it regards them as an emerging opioid threat.

Expect that paragraph to be out of date at some point. Do not let the legal status of a product be how you decide whether it is doing something to you.

I see people taking them in quantities they would never have accepted from a prescription pad, often for years, often on the specific belief that a plant-derived product sold legally cannot be an opioid. Many started using kratom precisely to get off opioids on their own — which is not a foolish idea, and is exactly how a substantial number of people ended up more dependent than when they began.

It is treatable, and it is treated with the same tools. Depending on the situation, that means a structured, medically supervised taper, or buprenorphine — either as a bridge through the transition or as ongoing maintenance — plus the same symptom management and the same attention to whatever the kratom was doing for you in the first place, which is usually pain, anxiety, or energy. What I need from you is an honest accounting of the product and the amount. Bring the package if you have it. The dose on the label is frequently not the dose in the product, and I would rather plan around what you are actually taking.

I have written more about kratom dependence specifically in an earlier post.

Somewhere after the acute phase settles, a lot of people hit a second wall. Sleep that is broken and unrefreshing. Anxiety with no obvious source. A flatness where enjoyment used to live, so that things you used to like simply do not land. Irritability, low energy, trouble concentrating. And cravings that arrive in waves — sometimes months in, sometimes out of nowhere on an otherwise good day.

This is what clinicians often call post-acute withdrawal. It is not a formal diagnosis — it does not appear in the DSM or the ICD — but it is well described, most of us who do this work see it constantly, and it is one of the main reasons people who did everything right return to use. Not for lack of resolve. Because they feel terrible, nobody told them they would, and they conclude that recovery simply feels like this and always will.

It doesn't. What you are experiencing is a brain recalibrating. Your reward and stress systems spent a long time adapting to a substance, and unwinding that adaptation takes weeks to months, not days. It gets better: the bad stretches get shorter, the good stretches get longer, and the waves get further apart.

Much of what people fear about "getting clean" is really a description of this long tail of withdrawal in someone who is not on medication. And I treat this phase rather than just naming it. Sleep gets addressed specifically and seriously, because insomnia left alone is its own relapse risk. Depression and anxiety get treated on their own merits, not waved off as "just early recovery." Gabapentin — used off-label for this, on a modest evidence base — helps some patients with the restlessness and the broken sleep. And nutrition, movement, and structure sound like small talk, but they genuinely change how these weeks feel.

A large part of the treatment is simply knowing it is coming. Patients who expect the second wall get over it. Patients who are blindsided by it too often decide the whole thing isn't working.

I said I would come back to this, and it is important enough to have its own section.

Tolerance drops fast — within days. The periods of highest overdose risk are precisely the ones that look like progress from the outside.

I want to put numbers on that, because it is the part people find hardest to believe. The same BMJ meta-analysis behind Figure 5 also looked at when people die after leaving treatment.

The supply itself has also changed. Much of what is sold as a pill on the street is now fentanyl, or a chemical cousin of it made to do the same thing. The amount varies between batches and even within the same batch. Xylazine and other things have been mixed into a great deal of it, which changes what an overdose looks like — xylazine does not respond to naloxone the way opioids do, which is a reason to give the naloxone and call 911 anyway, not a reason to skip it.

If you are using, test strips for fentanyl and xylazine are worth having, using with someone else present is safer than using alone, and there are hotlines that will stay on the phone with you. None of that is an endorsement of continued use. It is an acknowledgment that people are safer alive, and that I would rather have this conversation with you than have it about you.

I prescribe, and I believe in what I prescribe. I also know that medication alone is rarely the whole answer, because this is not only a chemical problem. It is bound up in how you handle stress, who you spend time with, how you fill a day, and what you do with a feeling you do not want to feel. Medicine does not solve those. People and practice do.

Mutual support

Narcotics Anonymous is the most widely available option and has helped an enormous number of people. I will give you one honest caution: some NA groups hold the view that people on buprenorphine or methadone are not truly in recovery, and I have watched patients be told exactly that. If that happens to you, it is a fact about that room, not about you or your treatment.

Because of that, I point people toward the full range. Medication-Assisted Recovery Anonymous (MARA) is built specifically for people on medication and does not have that problem. SMART Recovery uses cognitive-behavioral and motivational tools, is explicitly secular, and is explicitly supportive of medication. Recovery Dharma approaches it through Buddhist practice and meditation. Celebrate Recovery is explicitly Christian and fits naturally for people whose faith community is already central to their lives. There are others, including online meetings of nearly every flavor.

My advice: try more than one, and do not judge the whole category by one bad room. The group that fits is usually less about the philosophy on the wall and more about whether you feel like you belong in that room.

Structured programs

Sometimes an appointment every week or two is not enough support, and that is a dosing question rather than a character judgment.

Therapy and family

Individual therapy — especially with someone who understands addiction — does work a medication visit cannot. And if the people you live with want to be involved, there is often a real role for them, including learning to use naloxone.

You will not leave with a finished plan for the next five years, because I do not think anyone can honestly write one. You will leave with a plan for the next stretch: what medication you are starting and exactly how, what to do if things go sideways, when I want to see you again, how to reach us in between, naloxone in hand, and one or two concrete next steps.

Early on, visits are frequent — sometimes within days, especially around starting medication. As things stabilize, we spread out. We recheck labs. We adjust doses; if your dose is too low you will keep having cravings, and finding the right dose is ordinary medical work, not a negotiation. We talk about what is working and what isn't.

And if you use again, I want you to come in and tell me. Return to use is part of the clinical picture of a chronic disease, not proof that treatment failed, and not a reason to feel ashamed in my office. It is information. It usually means the dose is wrong, the support is thin, or something in your life changed — all of which are fixable. Adjusting the plan is my job.

I do not discharge people for having the illness I treat.

One last thing

You do not need to have decided anything before you come in. You do not need to have stopped already, or to know whether you want to be on medication forever, or to have a speech prepared. You do not need to arrive at a particular point in withdrawal, and you do not need to be afraid of what a drug test will show.

You need to be willing to sit down and have an honest conversation, and I will handle the rest of it with you.

When you are ready, come in. We will take it one step at a time.